Named on one round in the feed.
Since 2025-11-25
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Phrontline Biopharma Phrontline Biopharma develops innovative antibody-drug conjugates (ADCs) focused on oncology therapies. | Pre-A Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $60M | 2025-11-25 | [ PART ] |